Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAECOVID-19의 신경 학적 프리젠 테이션 : UAE, Abu Dhabi의 입원 환자 시리즈의 특징적인 특징Observational Study Published on 2021-08-062022-09-10 Journal: BioMed Research International [Category] 바이오마커, 임상, [키워드] Abnormalities abnormality Abu acute cerebrovascular disease age average Brain Brain infection Cerebrovascular disease city Comorbidities correlated COVID-19 COVID-19 patient COVID-19 patients cranial Cranial nerve CRP death diagnosed with COVID-19 died disease Dizziness duration of hospitalization Encephalopathy enrolled exhibited feature ferritin Fever had no headache higher risk Hospital stay Hyposmia hypoxia immune reaction inflammatory markers Ischemia Mortality myalgia myositis Neuroimaging neurological Neurological involvement neurological manifestation neurological manifestations not differ observational study oedema Older age outcome pathology Patient patients Peripheral Neuropathy presentation procalcitonin respiratory respiratory manifestation respiratory manifestations respiratory symptoms Result retrospective risk risk of death Seizures Serum ferritin Sery severe disease Sex small vessel stroke weakness [DOI] 10.1155/2021/5822259 PMC 바로가기 [Article Type] Observational Study
Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAEObservational Study Published on 2021-08-062022-10-27 Journal: BioMed Research International [Category] COVID-19, [키워드] abnormality Abu acute cerebrovascular disease age average Brain Brain infection city Comorbidities correlated COVID-19 COVID-19 patient cranial CRP death diagnosed with COVID-19 died disease Dizziness duration of hospitalization Encephalopathy enrolled exhibited feature ferritin Fever had no headache higher risk Hospital stay Hyposmia hypoxia immune reaction inflammatory markers Ischemia Mortality myalgia neurological Neurological involvement neurological manifestation neurological manifestations not differ oedema Older age outcome pathology Patient patients presentation procalcitonin respiratory manifestation respiratory symptoms Result retrospective risk risk of death Seizures Sery severe disease Sex small vessel stroke weakness [DOI] 10.1155/2021/5822259 PMC 바로가기 [Article Type] Observational Study
A Systematic Review of Characteristics Associated with COVID-19 in Children with Typical Presentation and with Multisystem Inflammatory SyndromeReview Published on 2021-08-042022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, [키워드] Adults Anosmia article Asymptomatic Characteristics children Chinese clinical information coronavirus disease cough COVID-19 diarrhea English evaluated exhibited exhibiting Fever global pandemic greater heterogeneous hyperinflammation Inflammatory Kawasaki-like less lymphocytopenia MIS-C nausea/vomiting patients pediatric positive presentation presenting Rash respiratory symptom returned review SARS-CoV-2 setting Shortness of breath sore throat Symptom syndrome systematic review Typical weakness with COVID-19 [DOI] 10.3390/ijerph18168269 PMC 바로가기 [Article Type] Review
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patientsNetosis 마커 및 습기의 진화는 중환자가 아픈 Covid-19 환자에서 예후 가치가 있습니다.Article Published on 2021-08-032022-08-31 Journal: Scientific Reports [Category] MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] (cfDNA) Acute inflammation Cell cfDNA Clinical parameters controls coronavirus coronavirus disease coronavirus disease 19 correlated COVID-19 COVID-19 patient COVID-19 patients Critically ill damage DAMP decrease disease severities disease severity Disease-free survival DNA event Evolution Extracellular GAS6 ICU ICU admission immune Infection intensive care intensive care unit lead lowering lowest marker measure molecular pattern molecular patterns Mortality multi-organ dysfunction NETosis neutrophil neutrophil counts Neutrophil elastase Neutrophils Occurrence parameter parameters Patient patient survival plasma Prognostic value Respiratory failure Respiratory tract diseases scoring system Sepsis severe COVID-19 survival the patient tissue damage Ventilator-free days viral infection weakness [DOI] 10.1038/s41598-021-95209-x PMC 바로가기 [Article Type] Article
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valleyGardena Valley의 일반 인구에서 SARS-CoV-2에 대한 혈청 항체의 유병률 및 결정인자Original Paper Published on 2021-08-032022-09-12 Journal: Epidemiology and Infection [Category] MERS, SARS, 진단, [키워드] 95% CI Abbott adjusted age analysed bioassay characteristic Community coronavirus COVID-19 COVID-19 pandemic Critical determinant Europe expansion phase Fever General population greater Infection Logistic regression neutralisation neutralisation titre Neutralising Antibodies Prevalence random reflected SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 seroprevalence Seropositivity serum serum antibody Sex Spread stratified threshold weakness [DOI] 10.1017/S0950268821001886 PMC 바로가기 [Article Type] Original Paper
COVID 19 infection associated with thrombotic thrombocytopenic purpura혈전성 혈소판 감소성 자반병과 관련된 코로나19 감염Case Reports Published on 2021-08-012022-09-12 Journal: Journal of Thrombosis and Thrombolysis [Category] MERS, SARS, 진단, [키워드] ADAMTS13 Admission association caused cleaving COVID COVID 19 deficiency diagnosed discharged example female Infection injection maintain management Mortality Patient plasma Platelet positive protease purpura rituximab Specific Therapeutic plasma exchange thrombosis thrombotic Thrombotic thrombocytopenic purpura TPE Vincristine in TTP. vWF weakness [DOI] 10.1007/s11239-021-02452-0 PMC 바로가기 [Article Type] Case Reports
Serum Metabolic Profile in Patients With Long-C ovid (PASC) Syndrome: Clinical ImplicationsMedicine Published on 2021-07-222022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] albumin alteration Anti-inflammatory anticoagulant therapy Blood clinical clinical conditions clinically Coagulation Concentration concomitant disease COVID-19 CRP D-dimer Dyspnea Elevation erythrocyte sedimentation rate evaluated fatigue ferritin hemoglobin hospital discharge implicated indicated Inflammation knowledge LDH Long-COVID-syndrome Long-term follow-up maintain marker metabolic metabolism molecular muscular PASC pathophysiology Patient patient symptom patients persistence profile Prophylactic Protein raise rehabilitation reported risk SARS-COV-2 infection SARS-CoV2 selected serum Seven Symptom syndrome thromboembolic disease virus infection weakness [DOI] 10.3389/fmed.2021.714426 PMC 바로가기 [Article Type] Medicine
Acute motor-sensory axonal polyneuropathy variant of Guillain–Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report코로나바이러스 질병 2019 감염의 회복 단계를 복잡하게 하는 Guillain-Barre 증후군의 급성 운동 감각 축삭 다발신경병증 변이: 증례 보고Case Reports Published on 2021-07-162022-09-10 Journal: Journal of Medical Case Reports [Category] SARS, 변종, 진단, [키워드] affected AMSAN Case report China clinical suspicion Complete coronavirus disease COVID-19 Desaturation diagnosed Diagnosis diagnostic workup disease early diagnosis effective GBS Guillain–Barrè syndrome heterogeneity Human Immunoglobulin individuals Intravenous immunoglobulin mandatory muscle weakness Novel coronavirus older patient older patients organ organ system outcome oxygen Patient Recovery phase reported shown sudden onset Symptom syndrome the disease therapeutic intervention therapeutic interventions variant weakness while [DOI] 10.1186/s13256-021-02988-y PMC 바로가기 [Article Type] Case Reports
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trialSARS Cov-2 감염으로 입원한 환자에서 아스피린, 아토르바스타틴, 니코란딜을 사용한 삼중 요법의 효능과 안전성을 평가하기 위한 무작위 공개 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-07-152022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 ACHE Acute coronary syndrome Acute kidney injury acute renal failure adequate hydration adjuvant therapy Admission allergy ALT/AST Altered mental status Anti-inflammatory anticoagulation antipyretics Antithrombotic approved ARDS Aspirin AST/ALT atorvastatin bleeding Blinding block randomization Breastfeeding brown urine change characterized clinical clinical feature Clinical features Coagulopathy college Combination comorbid condition comorbid conditions comparator conducted control group coronary syndrome Corticosteroid Corticosteroids cough COVID-19 CPK creatine creatine kinase creatinine CRP current therapy Dexamethasone dissemination dose drug dysfunction Dyspnoea dysregulation effective Efficacy and safety element Endothelial dysfunction enrolled ethical committee evaluate excluded ferritin Fever followed by greater heparin hepatotoxicity Hospital admission hospital discharge Hospital mortality Hospital stay hospitalised patient Hospitalised patients hyperbilirubinemia hypoxia ICMR IEC immune dysregulation immunomodulatory impaired consciousness in-hospital mortality India Inflammation Inflammatory marker inflammatory markers Intervention intervention group intolerance intravenous Intravenous remdesivir invasive limit liver low molecular weight low molecular weight heparin management marker mechanical ventilation medication medications moderate muscle ache myalgia Myoglobin Myopathy myositis national guidelines Nicorandil Non-invasive number objective once daily Open-label open-label trial outcome oxygen Oxygen requirement oxygen support participant pathophysiologic pathophysiology Patient Platelet Platelet count Pneumonia positive Pregnancy Primary outcome progression protocol raised Rajendra Prasad Randomised control trial randomization randomize Randomized Randomized controlled trial randomly divided receive recruitment reducing mortality Registered registry Remdesivir renal failure reported respiratory rate rhabdomyolysis room air RT-PCR safety endpoint safety endpoints Sample size SARS-CoV-2 infected patient SARS-COV-2 infection Schematic screened Secondary outcomes Sepsis serum serum markers severe disease Shock significant interaction SpO2 Standard Standard of care starting dose statin statins Study design Study protocol substrates supplementary material Symptom Symptomatic treatment Tablet therapeutic therapeutic agent therapy thrombocytopenia Treatment Trial Trial registration two-arm parallel ULN Urine weakness website [DOI] 10.1186/s13063-021-05361-y PMC 바로가기 [Article Type] Letter
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow upSARS-CoV-2 감염과 관련된 Guillain-Barré 증후군: 장기간 추적 관찰한 증례 보고Case Reports Published on 2021-07-152022-09-12 Journal: Journal of neuroimmunology [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome association Bangladesh Campylobacter jejuni Case report Clinical outcome complete recovery Coronavirus-2 COVID-19 diagnosed Electrophysiology Guillain-barrè syndrome Haemophilus hepatitis E virus Herpe IgG Inflammatory Intravenous immunoglobulin male Mycoplasma pneumoniae positive SARS-CoV-2 SARS-COV-2 infection Standard dose syndrome virus weakness Zika virus [DOI] 10.1016/j.jneuroim.2021.577590 PMC 바로가기 [Article Type] Case Reports